Advertisement

Topics

Hikma Stock Dips On Cut In FY Outlook; H1 Profit Up; To Expand Deal With Takeda

05:42 EDT 17 Aug 2017 | FinanzNachrichten

LONDON (dpa-AFX) - Shares of Hikma Pharmaceuticals Plc (HIK.L, HKMPY) declined around 12 percent in the morning trading in London after the company reduced its fiscal 2017 outlook for group revenu...

Original Article: Hikma Stock Dips On Cut In FY Outlook; H1 Profit Up; To Expand Deal With Takeda

NEXT ARTICLE

More From BioPortfolio on "Hikma Stock Dips On Cut In FY Outlook; H1 Profit Up; To Expand Deal With Takeda"

Advertisement
Quick Search
Advertisement
Advertisement